首页 > 最新文献

GMS Hygiene and Infection Control最新文献

英文 中文
Molecular detection of phenol-soluble modulin-mec (PSM-mec) in Staphylococcus aureus clinical isolates from Federal Medical Center Birnin Kebbi, North-West, Nigeria. 尼日利亚西北部Birnin Kebbi联邦医学中心金黄色葡萄球菌临床分离株酚溶性调素-mec的分子检测
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-03-06 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000538
Isah Musa Maishanu, Adeshina O Gbonjubola, Hussaini Mujahid, Busayo O Olayinka

Aim: This study was carried out to isolate and detect virulence genes associated with Staphylococcus (S.) aureus clinical isolates from the Federal Medical Center Birnin Kebbi, Nigeria.

Methods: To obtain S. aureus isolates, samples were taken from urine, sputum, blood and wound sources. S. aureus was phenotypically identified using Microgen staph ID system and PSM-mec and PVL genes were detected using polymerase chain reaction (PCR).

Results: A total of 48 non-duplicate S. aureus isolates were obtained (21 from wound swabs, 7 from blood, 15 from urine, and 5 from sputum). From the 14 S. aureus isolates examined by PCR, the most abundant gene was PSM-mec (42.8%), while the PVL was the least abundant with 21.4%.

Conclusion: Because it gives highly specific and accurate results, it is essential to use the PCR technique to detect S. aureus virulence determinants as well as PSM-mec and PVL as targets for antimicrobial agents.

目的:本研究旨在分离和检测来自尼日利亚Birnin Kebbi联邦医学中心的金黄色葡萄球菌临床分离株的毒力基因。方法:从尿液、痰液、血液和伤口源提取金黄色葡萄球菌分离株。采用Microgen葡萄球菌ID系统对金黄色葡萄球菌进行表型鉴定,采用聚合酶链反应(PCR)检测PSM-mec和PVL基因。结果:共分离到48株非重复金黄色葡萄球菌(伤口拭子21株,血液7株,尿液15株,痰液5株)。PCR检测的14株金黄色葡萄球菌中,PSM-mec基因丰度最高(42.8%),PVL基因丰度最低(21.4%)。结论:利用PCR技术检测金黄色葡萄球菌毒力决定因子,以及PSM-mec和PVL作为抗菌药物的靶点,具有较高的特异性和准确性。
{"title":"Molecular detection of phenol-soluble modulin-mec (PSM-mec) in Staphylococcus aureus clinical isolates from Federal Medical Center Birnin Kebbi, North-West, Nigeria.","authors":"Isah Musa Maishanu, Adeshina O Gbonjubola, Hussaini Mujahid, Busayo O Olayinka","doi":"10.3205/dgkh000538","DOIUrl":"https://doi.org/10.3205/dgkh000538","url":null,"abstract":"<p><strong>Aim: </strong>This study was carried out to isolate and detect virulence genes associated with <i>Staphylococcus (S.) aureus</i> clinical isolates from the Federal Medical Center Birnin Kebbi, Nigeria.</p><p><strong>Methods: </strong>To obtain <i>S. aureus</i> isolates, samples were taken from urine, sputum, blood and wound sources. <i>S. aureus</i> was phenotypically identified using Microgen staph ID system and PSM-mec and PVL genes were detected using polymerase chain reaction (PCR).</p><p><strong>Results: </strong>A total of 48 non-duplicate <i>S. aureus</i> isolates were obtained (21 from wound swabs, 7 from blood, 15 from urine, and 5 from sputum). From the 14 <i>S. aureus</i> isolates examined by PCR, the most abundant gene was <i>PSM-mec</i> (42.8%), while the PVL was the least abundant with 21.4%.</p><p><strong>Conclusion: </strong>Because it gives highly specific and accurate results, it is essential to use the PCR technique to detect <i>S. aureus</i> virulence determinants as well as PSM-mec and PVL as targets for antimicrobial agents.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc09"},"PeriodicalIF":1.7,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144013626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor regarding the paper "S2k-Guideline hand antisepsis and hand hygiene". 就《s2k手部消毒和手部卫生指南》一文致编辑的信。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-03-06 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000537
Maren Eggers, Katrin Steinhauer, Florin H H Brill
{"title":"Letter to the editor regarding the paper \"S2k-Guideline hand antisepsis and hand hygiene\".","authors":"Maren Eggers, Katrin Steinhauer, Florin H H Brill","doi":"10.3205/dgkh000537","DOIUrl":"https://doi.org/10.3205/dgkh000537","url":null,"abstract":"","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc08"},"PeriodicalIF":1.7,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hygiene and disinfection measures for parvovirus B19 infections. 细小病毒B19感染的卫生及消毒措施。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-03-05 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000534
Maren Eggers, Nils-Olaf Hübner, Ulrike Helber-Soszynski, Johannes Blümel, Martin Exner, Jürgen Gebel, Carola Ilschner, Holger F Rabenau, Ingeborg Schwebke, Martin Enders

Background: In 2024, there has been a notable surge in the incidence of infections with parvovirus B19 (B19V). This development presents significant challenges, particularly for pregnant women, daycare centers, and medical facilities with vulnerable patients.

Properties of b19v: B19V is transmitted primarily by droplet infection, directly and indirectly through contaminated surfaces. It is highly contagious and can have serious health consequences for at-risk groups, especially for pregnant women and immunocompromised individuals. There is not yet much data available on the specific tenacity/replication capacity of B19V, which is why empirical values from animal parvoviruses regarding sensitivity to disinfectants are used.

Recommendations for hygiene measures: In order to prevent the further spread of B19V, an advisory has been prepared by experts from the Association for Applied Hygiene (VAH), in collaboration with the "Virus Disinfection" commission of the German Association for the Control of Virus Diseases (DVV) and the Society for Virology (GfV). This advisory is based on a risk assessment and the specific properties of B19V, and it outlines the necessary hygiene measures, including the selection of suitable disinfectants, to be taken in various areas in order to prevent the virus from spreading further. In the domestic setting, fundamental hygiene practices include thorough handwashing, refraining from touching the eyes, mouth, and nose, the use of a medical mask in the absence of physical distancing, and the frequent ventilation of rooms. In a medical setting, for example, the disinfection of surfaces in close proximity to the patient with an active virucidal agent and the use of gloves are also recommended when dealing with infected or potentially infected individuals.

背景:2024年,细小病毒B19 (B19V)感染的发病率显著上升。这一发展带来了重大挑战,特别是对孕妇、日托中心和有弱势病人的医疗机构。b19v病毒的特性:b19v病毒主要通过飞沫传播,可直接或间接通过被污染的表面传播。它具有高度传染性,可对高危人群,特别是孕妇和免疫功能低下者造成严重的健康后果。目前关于B19V病毒的具体韧性/复制能力的数据还不多,因此使用了动物细小病毒对消毒剂敏感性的经验值。卫生措施建议:为了防止B19V的进一步传播,应用卫生协会(VAH)的专家与德国病毒疾病控制协会(DVV)和病毒学学会(GfV)的“病毒消毒”委员会合作,编写了一份咨询报告。该咨询是根据风险评估和B19V的具体特性制定的,它概述了在各个地区采取的必要卫生措施,包括选择合适的消毒剂,以防止病毒进一步传播。在家庭环境中,基本卫生习惯包括彻底洗手,避免触摸眼睛、嘴巴和鼻子,在没有物理距离的情况下使用医用口罩,以及房间经常通风。例如,在医疗环境中,在处理感染者或潜在感染者时,还建议使用活性杀病毒剂对患者附近的表面进行消毒,并使用手套。
{"title":"Hygiene and disinfection measures for parvovirus B19 infections.","authors":"Maren Eggers, Nils-Olaf Hübner, Ulrike Helber-Soszynski, Johannes Blümel, Martin Exner, Jürgen Gebel, Carola Ilschner, Holger F Rabenau, Ingeborg Schwebke, Martin Enders","doi":"10.3205/dgkh000534","DOIUrl":"https://doi.org/10.3205/dgkh000534","url":null,"abstract":"<p><strong>Background: </strong>In 2024, there has been a notable surge in the incidence of infections with parvovirus B19 (B19V). This development presents significant challenges, particularly for pregnant women, daycare centers, and medical facilities with vulnerable patients.</p><p><strong>Properties of b19v: </strong>B19V is transmitted primarily by droplet infection, directly and indirectly through contaminated surfaces. It is highly contagious and can have serious health consequences for at-risk groups, especially for pregnant women and immunocompromised individuals. There is not yet much data available on the specific tenacity/replication capacity of B19V, which is why empirical values from animal parvoviruses regarding sensitivity to disinfectants are used.</p><p><strong>Recommendations for hygiene measures: </strong>In order to prevent the further spread of B19V, an advisory has been prepared by experts from the Association for Applied Hygiene (VAH), in collaboration with the \"Virus Disinfection\" commission of the German Association for the Control of Virus Diseases (DVV) and the Society for Virology (GfV). This advisory is based on a risk assessment and the specific properties of B19V, and it outlines the necessary hygiene measures, including the selection of suitable disinfectants, to be taken in various areas in order to prevent the virus from spreading further. In the domestic setting, fundamental hygiene practices include thorough handwashing, refraining from touching the eyes, mouth, and nose, the use of a medical mask in the absence of physical distancing, and the frequent ventilation of rooms. In a medical setting, for example, the disinfection of surfaces in close proximity to the patient with an active virucidal agent and the use of gloves are also recommended when dealing with infected or potentially infected individuals.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc05"},"PeriodicalIF":1.7,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144063460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Better care for children with appendicitis: implementation of antibiotic stewardship optimizes postoperative therapy. 阑尾炎患儿更好的护理:抗生素管理的实施优化了术后治疗。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-03-05 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000535
Sebastian Beltz, Stephanie Fischer, Frank Huenger, Reza Vahdad, Hermann Kalhoff, Andreas Leutner

Aim: Appendectomy is the most frequent emergency abdominal operation in children, who regularly present with complicated acute appendicitis and thus need targeted antibiotic therapy. While in other fields antibiotic stewardship (ABS) is becoming increasingly well established, these principles are not consistently followed in pediatric surgery. With this study, we aimed to analyze the effects of the implementation of an ABS-compliant SOP on the postoperative care of patients.

Material and methods: We compared the quality of antibiotic therapy before and after the implementation of standard operating procedure (SOP) for the peri-/postoperative antibiotic treatment of appendicitis in 2020. Pediatric patients who had undergone appendectomy were evaluated based on an algorithm presenting recommended antibiotic therapy of appendicitis, according to the current literature and good clinical practice. 165 patients were evaluated before and 209 patients after the implementation of SOP.

Results: The mean number of cases in which antibiotic therapy was given postoperatively was 10.5% lower (p-value 0.036) and the median quality-of-treatment score increased by 31.2% (p<0.0001) after the implementation of the SOP. The median length of antibiotic treatment in cases of advanced-stage appendicitis was 2.0 days shorter (p=0.062). The rate of oral antibiotic treatment after discharge decreased by 25.6% (p<0.0001). We observed no significant effects on the median length of hospital stay or the complication rate.

Conclusion: The implementation of SOP based on the principles of ABS positively influenced the quality of treatment after pediatric appendectomy. The algorithm developed in this study may help pediatric surgeons to improve their antimicrobial assessment.

目的:阑尾切除术是儿童最常见的急诊腹部手术,儿童经常出现复杂的急性阑尾炎,需要有针对性的抗生素治疗。虽然在其他领域抗生素管理(ABS)正变得越来越完善,但这些原则并没有在儿科手术中得到一致的遵循。通过这项研究,我们旨在分析实施符合abs标准的SOP对患者术后护理的影响。材料与方法:比较2020年阑尾炎围手术期/术后抗生素治疗标准操作规程(SOP)实施前后的抗生素治疗质量。根据目前的文献和良好的临床实践,根据推荐的阑尾炎抗生素治疗算法对接受阑尾切除术的儿科患者进行评估。实施SOP前165例,实施SOP后209例。结果:术后给予抗生素治疗的平均例数减少了10.5% (p值为0.036),治疗质量评分中位数提高了31.2% (p)。结论:基于ABS原则的SOP的实施对小儿阑尾切除术后的治疗质量有积极影响。本研究中开发的算法可以帮助儿科外科医生改善他们的抗菌评估。
{"title":"Better care for children with appendicitis: implementation of antibiotic stewardship optimizes postoperative therapy.","authors":"Sebastian Beltz, Stephanie Fischer, Frank Huenger, Reza Vahdad, Hermann Kalhoff, Andreas Leutner","doi":"10.3205/dgkh000535","DOIUrl":"https://doi.org/10.3205/dgkh000535","url":null,"abstract":"<p><strong>Aim: </strong>Appendectomy is the most frequent emergency abdominal operation in children, who regularly present with complicated acute appendicitis and thus need targeted antibiotic therapy. While in other fields antibiotic stewardship (ABS) is becoming increasingly well established, these principles are not consistently followed in pediatric surgery. With this study, we aimed to analyze the effects of the implementation of an ABS-compliant SOP on the postoperative care of patients.</p><p><strong>Material and methods: </strong>We compared the quality of antibiotic therapy before and after the implementation of standard operating procedure (SOP) for the peri-/postoperative antibiotic treatment of appendicitis in 2020. Pediatric patients who had undergone appendectomy were evaluated based on an algorithm presenting recommended antibiotic therapy of appendicitis, according to the current literature and good clinical practice. 165 patients were evaluated before and 209 patients after the implementation of SOP.</p><p><strong>Results: </strong>The mean number of cases in which antibiotic therapy was given postoperatively was 10.5% lower (p-value 0.036) and the median quality-of-treatment score increased by 31.2% (p<0.0001) after the implementation of the SOP. The median length of antibiotic treatment in cases of advanced-stage appendicitis was 2.0 days shorter (p=0.062). The rate of oral antibiotic treatment after discharge decreased by 25.6% (p<0.0001). We observed no significant effects on the median length of hospital stay or the complication rate.</p><p><strong>Conclusion: </strong>The implementation of SOP based on the principles of ABS positively influenced the quality of treatment after pediatric appendectomy. The algorithm developed in this study may help pediatric surgeons to improve their antimicrobial assessment.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc06"},"PeriodicalIF":1.7,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality in Frankfurt am Main, Germany, 2020-2023: higher excess mortality during an influenza wave in 2022 than during all COVID-19 waves altogether. 2020-2023年德国美因河畔法兰克福的死亡率:2022年流感波期间的超额死亡率高于所有COVID-19波期间的死亡率总和。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-03-04 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000533
Ursel Heudorf, Bernd Kowall
<p><strong>Introduction: </strong>Mortality during the SARS-CoV-2 pandemic was studied in many countries. The results were strongly influenced by the chosen calculation method, the adjustment to the ageing of the population and the reference periods used. Smaller-scale studies sometimes showed considerable differences within countries, but it is unclear whether the differences within a country were due to the fact that the studies were small (sampling error) or whether they were true differences. In an earlier small-scale study in Frankfurt, we examined mortality during the first two years of the pandemic. Our aim was to continue this analysis until the end of 2023, for the first time taking into account other factors influencing mortality such as influenza and heat.</p><p><strong>Method: </strong>We obtained population data for Frankfurt am Main for 2016-2023 from the Municipal Office of Statistics, City of Frankfurt/Main, mortality data from 2016 to 2023 from the Hessian State Office for Health and Care, data on SARS-CoV-2 and influenza notifications from the homepage of the Robert Koch-Institute and weather data from the homepage of the German Meteorological Office. For calculating standardized mortality ratios (SMR= observed number of deaths divided by the expected number of deaths), we multiplied the mean mortality rate for 5 age groups from 2016-2019 with the total numer of residents in those age groups in the further years or periods, and finally added the numbers of expected deaths per age group.</p><p><strong>Results: </strong>The update of the assessment of mortality adjusted for age and population trend in the years 2020-2023 in Frankfurt am Main shows an excess mortality (SMR 1.029; 95% CI 1.004-1.054, +185 excess deaths) in 2022, followed by a negative excess mortality in 2023 (SMR 0.972; 95% CI 0.948-0.996). In the years 2020 and 2021 however, no increase in excess mortality had been found (2020: SMR 0.976; 95% CI 0.951-1.001; 2021: 0.998; 95% CI 0,973-1.023). In the second wave of the SARS CoV-2 pandemic with the Wuhan type (fall 2020), a significantly increased mortality was found (SMR 1.106; 95% CI 1.066-1.147, +274 deaths), as well as during the first four waves overall (Wuhan, Alpha and Delta type) (SMR 1.023; 95 CI 1.001-1.045), whereas no increased mortality occurred during the further waves with the Omikron variant in 2022 (SMR 0.988; 95% CI 0.963-1.014). The increased mortality in 2022 was associated with an influenza wave in the last 6 weeks of the year, which had led to a strong increase in mortality (SMR 1.250; 95% CI 1.170-1.330).</p><p><strong>Discussion: </strong>During the SARS-CoV-2 pandemic, significant excess mortality occurred in Frankfurt am Main only in the second wave at the end of 2020 before vaccination was introduced; in all other waves, no significant excess mortality was recorded. Overall, there was a non-significant negative excess mortality in Frankfurt am Main in 2020 and 2021 and a significant negativ
导言:许多国家对SARS-CoV-2大流行期间的死亡率进行了研究。结果受到所选择的计算方法、对人口老龄化的调整以及所使用的参考期的强烈影响。规模较小的研究有时显示出国家内部存在相当大的差异,但尚不清楚一国内部的差异是由于研究规模小(抽样误差)还是它们确实存在差异。在法兰克福早期的一项小规模研究中,我们检查了大流行头两年的死亡率。我们的目标是将这一分析持续到2023年底,这是第一次考虑到影响死亡率的其他因素,如流感和高温。方法:我们从法兰克福/美因市市政统计局获得2016-2023年美因河畔法兰克福的人口数据,从黑森州卫生与保健办公室获得2016-2023年的死亡率数据,从罗伯特科赫研究所主页获得SARS-CoV-2和流感通报数据,从德国气象局主页获得天气数据。为了计算标准化死亡率(SMR=观察死亡人数除以预期死亡人数),我们将2016-2019年5个年龄组的平均死亡率乘以这些年龄组在后续年份或期间的居民总数,最后加上每个年龄组的预期死亡人数。结果:美因河畔法兰克福2020-2023年经年龄和人口趋势调整的死亡率评估更新显示,死亡率过高(SMR 1.029;95% CI 1.004-1.054, +185例超额死亡),其次是2023年的负超额死亡率(SMR 0.972;95% ci 0.948-0.996)。然而,在2020年和2021年,没有发现超额死亡率增加(2020年:SMR 0.976;95% ci 0.951-1.001;2021: 0.998;95% ci 0,973-1.023)。在第二波武汉型SARS CoV-2大流行(2020年秋季)中,发现死亡率显著增加(SMR 1.106;95% CI 1.066-1.147, +274例死亡),以及前四波总体(武汉型、阿尔法型和德尔塔型)(SMR 1.023;95 CI 1.001-1.045),而在2022年的Omikron变异的进一步波浪中,死亡率没有增加(SMR 0.988;95% ci 0.963-1.014)。2022年死亡率的增加与该年最后6周的流感浪潮有关,导致死亡率大幅上升(SMR 1.250;95% ci 1.170-1.330)。讨论:在SARS-CoV-2大流行期间,美因河畔法兰克福仅在引入疫苗接种之前的2020年底的第二波中出现了显著的超额死亡率;在所有其他波浪中,没有记录到明显的超额死亡率。总体而言,美因河畔法兰克福在2020年和2021年出现了非显著负超额死亡率,在2023年出现了显著负超额死亡率。然而,在2022年,观察到死亡率大幅增加,这不能归因于SARS-CoV-2,而是归因于该年底最后6周的短暂、强烈的流感浪潮,这也导致整个德国的死亡率大幅上升。这波流感与美因河畔法兰克福的高死亡率有关,高于美因河畔法兰克福的任何一波SARS-CoV-2大流行。流感波期间的超额死亡人数大于所有SARS-CoV-2波期间的超额死亡人数。在对这一流行病进行评估时,应该考虑到这一显著事实,德国在许多方面越来越多地要求进行这一进程,但目前仍悬而未决。
{"title":"Mortality in Frankfurt am Main, Germany, 2020-2023: higher excess mortality during an influenza wave in 2022 than during all COVID-19 waves altogether.","authors":"Ursel Heudorf, Bernd Kowall","doi":"10.3205/dgkh000533","DOIUrl":"https://doi.org/10.3205/dgkh000533","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Mortality during the SARS-CoV-2 pandemic was studied in many countries. The results were strongly influenced by the chosen calculation method, the adjustment to the ageing of the population and the reference periods used. Smaller-scale studies sometimes showed considerable differences within countries, but it is unclear whether the differences within a country were due to the fact that the studies were small (sampling error) or whether they were true differences. In an earlier small-scale study in Frankfurt, we examined mortality during the first two years of the pandemic. Our aim was to continue this analysis until the end of 2023, for the first time taking into account other factors influencing mortality such as influenza and heat.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method: &lt;/strong&gt;We obtained population data for Frankfurt am Main for 2016-2023 from the Municipal Office of Statistics, City of Frankfurt/Main, mortality data from 2016 to 2023 from the Hessian State Office for Health and Care, data on SARS-CoV-2 and influenza notifications from the homepage of the Robert Koch-Institute and weather data from the homepage of the German Meteorological Office. For calculating standardized mortality ratios (SMR= observed number of deaths divided by the expected number of deaths), we multiplied the mean mortality rate for 5 age groups from 2016-2019 with the total numer of residents in those age groups in the further years or periods, and finally added the numbers of expected deaths per age group.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The update of the assessment of mortality adjusted for age and population trend in the years 2020-2023 in Frankfurt am Main shows an excess mortality (SMR 1.029; 95% CI 1.004-1.054, +185 excess deaths) in 2022, followed by a negative excess mortality in 2023 (SMR 0.972; 95% CI 0.948-0.996). In the years 2020 and 2021 however, no increase in excess mortality had been found (2020: SMR 0.976; 95% CI 0.951-1.001; 2021: 0.998; 95% CI 0,973-1.023). In the second wave of the SARS CoV-2 pandemic with the Wuhan type (fall 2020), a significantly increased mortality was found (SMR 1.106; 95% CI 1.066-1.147, +274 deaths), as well as during the first four waves overall (Wuhan, Alpha and Delta type) (SMR 1.023; 95 CI 1.001-1.045), whereas no increased mortality occurred during the further waves with the Omikron variant in 2022 (SMR 0.988; 95% CI 0.963-1.014). The increased mortality in 2022 was associated with an influenza wave in the last 6 weeks of the year, which had led to a strong increase in mortality (SMR 1.250; 95% CI 1.170-1.330).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;During the SARS-CoV-2 pandemic, significant excess mortality occurred in Frankfurt am Main only in the second wave at the end of 2020 before vaccination was introduced; in all other waves, no significant excess mortality was recorded. Overall, there was a non-significant negative excess mortality in Frankfurt am Main in 2020 and 2021 and a significant negativ","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc04"},"PeriodicalIF":1.7,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143997259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing antibiotic stewardship: Physicians' acceptance of AWaRe (Access, Watch, Reserve)-based microbiology reporting and its impact on judicious antibiotic selection - a cross-sectional study. 加强抗生素管理:医生接受基于AWaRe(获取、观察、储备)的微生物报告及其对明智选择抗生素的影响——一项横断面研究。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-03-04 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000532
Heera Hassan, Aravind Reghukumar, Jyothi Rajahamsan, Sreenadh Harikumar, Manjusree Shanmugham

Background: Inappropriate and excessive use of antimicrobials contributes to the rise of antimicrobial resistance (AMR). To address this, better tools are needed to improve antibiotic prescribing globally. This study evaluates a novel antimicrobial stewardship (AMS) tool - the AWaRe-based microbiology reporting format - developed by the Departments of Microbiology and Infectious Diseases at the Government Medical College, Trivandrum, Kerala state, India. This format incorporates the WHO AWaRe classification into bacterial culture susceptibility reports. The primary objective was to assess the effectiveness of this reporting format in encouraging physicians to choose access antibiotics. The secondary objective was to identify the most preferred microbiology reporting format for antimicrobial susceptibility reports.

Materials and methods: A cross-sectional study was conducted among registered modern-medicine practitioners (physicians) in Kerala via social media platforms using a Google form-based questionnaire over a two-month period. Responses were automatically recorded and analysed using descriptive statistical methods. The study included all physicians who gave informed consent, excluding those who declined to participate. The sample size was determined to be 138 based on a pilot study.

Results: A total of 228 physicians participated in the study, 137 (60.1%) of which were clinicians. Among the participants, 199 (87.2%) preferred the AWaRe-based reporting format over conventional formats for effective implementation of the Antimicrobial Stewardship Programme (AMSP). Using this AMS tool, 76.7% (n=56) of participants were successfully guided to choose appropriate access antibiotics.

Conclusion: The study demonstrates that AWaRe-based susceptibility reporting formats can effectively nudge clinicians towards better antibiotic selection, supporting the successful implementation of AMSP (antibiotic stewardship programs). This format also serves as a continuous IEC (Information, Education and Communication) tool, helping clinicians familiarize themselves with WHO AWaRe classifications and encouraging the preferential selection of access-group antibiotics when appropriate.

背景:不适当和过度使用抗菌素导致抗菌素耐药性(AMR)上升。为了解决这一问题,需要更好的工具来改善全球的抗生素处方。本研究评估了一种新的抗菌剂管理(AMS)工具——基于aware的微生物报告格式——由印度喀拉拉邦特里凡得琅政府医学院微生物学和传染病系开发。该格式将WHO AWaRe分类纳入细菌培养药敏性报告。主要目的是评估这种报告格式在鼓励医生选择可获得抗生素方面的有效性。次要目的是确定抗菌药物敏感性报告的首选微生物报告格式。材料和方法:在两个月的时间里,通过社交媒体平台使用谷歌表格调查问卷,对喀拉拉邦的注册现代医学从业者(医生)进行了一项横断面研究。应答被自动记录并使用描述性统计方法进行分析。该研究包括所有给予知情同意的医生,不包括那些拒绝参与的医生。根据一项初步研究,样本量确定为138人。结果:共有228名医生参与研究,其中临床医生137人(60.1%)。在参与者中,199个(87.2%)更喜欢基于aware的报告格式,而不是有效实施抗菌药物管理规划(AMSP)的传统格式。使用该工具,76.7% (n=56)的参与者被成功引导选择合适的可及性抗生素。结论:该研究表明,基于aware的敏感性报告格式可以有效地推动临床医生更好地选择抗生素,支持AMSP(抗生素管理计划)的成功实施。这一格式还可作为一种持续的信息、教育和传播工具,帮助临床医生熟悉世卫组织AWaRe分类,并鼓励在适当情况下优先选择可获得组抗生素。
{"title":"Enhancing antibiotic stewardship: Physicians' acceptance of AWaRe (Access, Watch, Reserve)-based microbiology reporting and its impact on judicious antibiotic selection - a cross-sectional study.","authors":"Heera Hassan, Aravind Reghukumar, Jyothi Rajahamsan, Sreenadh Harikumar, Manjusree Shanmugham","doi":"10.3205/dgkh000532","DOIUrl":"https://doi.org/10.3205/dgkh000532","url":null,"abstract":"<p><strong>Background: </strong>Inappropriate and excessive use of antimicrobials contributes to the rise of antimicrobial resistance (AMR). To address this, better tools are needed to improve antibiotic prescribing globally. This study evaluates a novel antimicrobial stewardship (AMS) tool - the AWaRe-based microbiology reporting format - developed by the Departments of Microbiology and Infectious Diseases at the Government Medical College, Trivandrum, Kerala state, India. This format incorporates the WHO AWaRe classification into bacterial culture susceptibility reports. The primary objective was to assess the effectiveness of this reporting format in encouraging physicians to choose access antibiotics. The secondary objective was to identify the most preferred microbiology reporting format for antimicrobial susceptibility reports.</p><p><strong>Materials and methods: </strong>A cross-sectional study was conducted among registered modern-medicine practitioners (physicians) in Kerala via social media platforms using a Google form-based questionnaire over a two-month period. Responses were automatically recorded and analysed using descriptive statistical methods. The study included all physicians who gave informed consent, excluding those who declined to participate. The sample size was determined to be 138 based on a pilot study.</p><p><strong>Results: </strong>A total of 228 physicians participated in the study, 137 (60.1%) of which were clinicians. Among the participants, 199 (87.2%) preferred the AWaRe-based reporting format over conventional formats for effective implementation of the Antimicrobial Stewardship Programme (AMSP). Using this AMS tool, 76.7% (n=56) of participants were successfully guided to choose appropriate access antibiotics.</p><p><strong>Conclusion: </strong>The study demonstrates that AWaRe-based susceptibility reporting formats can effectively nudge clinicians towards better antibiotic selection, supporting the successful implementation of AMSP (antibiotic stewardship programs). This format also serves as a continuous IEC (Information, Education and Communication) tool, helping clinicians familiarize themselves with WHO AWaRe classifications and encouraging the preferential selection of access-group antibiotics when appropriate.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc03"},"PeriodicalIF":1.7,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and molecular fingerprint of SARS-CoV-2 among hospital employees in a period of Omicron BA.2 dominance. 欧米克隆ba2优势期医院员工SARS-CoV-2临床及分子指纹图谱分析
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-24 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000531
Dominic Rauschning, Ruth Weppler, Carsten Balczun, Gwendolyn Scheumann, Jasmin Monteiro Marques, Christina Mutschnik, Dominic Preuß, Ricarda Maria Schmithausen, Maximilian Starke, Ralf Matthias Hagen, Manuel Döhla

In the spring of 2022, SARS-CoV-2 Omicron BA.2 peaked in Germany. The main burden was staff shortage. To achieve effective identification and management of infected persons as well as early reintegration of recovered persons, an infection-control outpatient clinic was established at the Bundeswehr Central Hospital Koblenz. This article reports a secondary data analysis of 663 people with 1,174 visits to the outpatient clinic. For asymptomatic contacts, no correlation was observed between PCR result and testing time or frequency. Although no significant symptoms were documented, a high correlation was found between a positive antigen self-test and positive PCR. For clearance, a median time until a negative test was obtained was 8-11 days. The PCR gold standard was compared with ECLIA antigen testing for all indications. The results of this study challenge the rationale for testing asymptomatic contacts. Solely symptom-driven diagnostics by PCR also do not seem to be effective. However, contact persons or symptomatic persons with a positive rapid antigen test should be tested further. Whether this testing is done by ECLIA or PCR does not seem to matter. Clearance testing after recovery prior to day 8 is also not appropriate.

2022年春天,SARS-CoV-2 Omicron BA.2在德国达到顶峰。主要的负担是人员短缺。为了有效识别和管理感染者并使康复者早日重返社会,在科布伦茨联邦国防军中央医院设立了一个感染控制门诊诊所。本文报告了对663人1174次门诊就诊的二次数据分析。对于无症状接触者,PCR结果与检测时间和检测频率无相关性。虽然没有明显的症状记录,但抗原自检阳性与PCR阳性之间存在高度相关性。对于清除率,直到获得阴性试验的中位时间为8-11天。将PCR金标准与ECLIA抗原检测的所有适应症进行比较。这项研究的结果挑战了测试无症状接触者的基本原理。单靠症状驱动的PCR诊断似乎也不有效。但是,接触者或快速抗原检测呈阳性的有症状者应进一步进行检测。这项检测是用ECLIA还是PCR进行似乎并不重要。在康复后第8天之前进行清除率测试也是不合适的。
{"title":"Clinical and molecular fingerprint of SARS-CoV-2 among hospital employees in a period of Omicron BA.2 dominance.","authors":"Dominic Rauschning, Ruth Weppler, Carsten Balczun, Gwendolyn Scheumann, Jasmin Monteiro Marques, Christina Mutschnik, Dominic Preuß, Ricarda Maria Schmithausen, Maximilian Starke, Ralf Matthias Hagen, Manuel Döhla","doi":"10.3205/dgkh000531","DOIUrl":"https://doi.org/10.3205/dgkh000531","url":null,"abstract":"<p><p>In the spring of 2022, SARS-CoV-2 Omicron BA.2 peaked in Germany. The main burden was staff shortage. To achieve effective identification and management of infected persons as well as early reintegration of recovered persons, an infection-control outpatient clinic was established at the Bundeswehr Central Hospital Koblenz. This article reports a secondary data analysis of 663 people with 1,174 visits to the outpatient clinic. For asymptomatic contacts, no correlation was observed between PCR result and testing time or frequency. Although no significant symptoms were documented, a high correlation was found between a positive antigen self-test and positive PCR. For clearance, a median time until a negative test was obtained was 8-11 days. The PCR gold standard was compared with ECLIA antigen testing for all indications. The results of this study challenge the rationale for testing asymptomatic contacts. Solely symptom-driven diagnostics by PCR also do not seem to be effective. However, contact persons or symptomatic persons with a positive rapid antigen test should be tested further. Whether this testing is done by ECLIA or PCR does not seem to matter. Clearance testing after recovery prior to day 8 is also not appropriate.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc02"},"PeriodicalIF":1.7,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143997257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bactericidal and virucidal action of cetylpyridinium chloride and benzocaine lozenges against common oropharyngeal pathogens. 氯化十六烷基吡啶和苯佐卡因含片对常见口咽病原体的杀菌和杀病毒作用。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-02-24 eCollection Date: 2025-01-01 DOI: 10.3205/dgkh000530
Tina Peiter, Fergus de Grey-Warter, Tessa Stahl, Thomas Hallet, Derek Matthews, Maren Eggers

Aim: Too often, antibiotics are prescribed in the treatment of pharyngitis, which can contribute to antimicrobial resistance. We aimed to assess the in vitro antiviral and antimicrobial activity of sugar-free cetylpyridinium chloride (CPC)/benzocaine lozenges, which can potentially offer a more suitable treatment for pharyngitis.

Methods: The antiviral activity of sugar-free CPC/benzocaine (1.4 mg/10 mg) lozenges (Dolo-Dobendan 1.4 mg/10 mg lozenges) was assessed using the DIN EN 14476:2019-10 suspension test against bovine coronavirus (S379 Reims) or influenza virus A (H1N1/Brisbane/59/2007) under clean and dirty conditions. Viral titers were measured after 1, 5, 10, and 30 min exposure; a reduction of ≥4 lg was considered virucidal. For bovine coronavirus, large volume plating was used due to cytotoxicity. Antimicrobial activity was measured against 11 microorganisms associated with pharyngitis, with contact times of 1, 5, and 10 min (+30 min for positive control).

Results: For influenza, sugar-free lozenges showed ≥4 lg efficacy from 5 and 10 min exposure under clean and dirty conditions, respectively. For bovine coronavirus, sugar-free lozenges exhibited ≥4 lg efficacy at 10 min under both conditions. Bactericidal activity was observed against nine of the challenge microorganisms within 5 min, with plate counts of <10 colony-forming units (CFU)/mL for Pseudomonas aeruginosa, Staphylococcus aureus, Arcanobacterium haemolyticum, Moraxella catarrhalis, Porphyromonas gingivalis, Prevotelia intermedia, Streptococcus dysgalactiae, and Streptococcus pyogenes, and <100 CFU/mL for Streptococcus pneumoniae. Candida albicans and Escherichia coli showed counts of <10 CFU/mL at 30 min.

Conclusions: Sugar-free CPC/benzocaine lozenges can be recommended for uncomplicated pharyngitis and may be more appropriate than antibiotics, helping to mitigate antimicrobial resistance.

目的:在治疗咽炎时经常使用抗生素,这可能导致抗菌素耐药性。我们的目的是评估无糖十六烷基吡啶氯化(CPC)/苯佐卡因含片的体外抗病毒和抗菌活性,该含片可能为治疗咽炎提供更合适的方法。方法:采用DIN EN 14476:2019-10对牛冠状病毒(S379 Reims)或甲型流感病毒(H1N1/Brisbane/59/2007)的悬浮液试验,在清洁和脏脏条件下评估无糖CPC/苯佐卡因(1.4 mg/ 10mg)含片(Dolo-Dobendan 1.4 mg/ 10mg含片)的抗病毒活性。暴露1、5、10和30分钟后检测病毒滴度;减少≥4 lg被认为是有病毒的。对于牛冠状病毒,由于细胞毒性,采用大容量电镀。对11种与咽炎相关的微生物进行抑菌活性测定,接触时间分别为1、5和10分钟(阳性对照+30分钟)。结果:对于流感,无糖含片在清洁和肮脏条件下分别在5和10分钟暴露时显示≥4 lg的疗效。对于牛冠状病毒,在两种条件下,无糖含片在10分钟内均表现出≥4 lg的疗效。在5分钟内观察到对9种攻毒微生物的杀菌活性,其中铜绿假单胞菌、金黄色葡萄球菌、溶血隐菌、卡他莫拉菌、牙龈卟啉单胞菌、中间普雷沃氏菌、泌乳不良链球菌、化脓性链球菌和肺炎链球菌的平板计数。结论:无糖CPC/苯佐卡因含片可推荐用于无并发症咽炎,可能比抗生素更合适,有助于减轻抗菌药物耐药性。
{"title":"Bactericidal and virucidal action of cetylpyridinium chloride and benzocaine lozenges against common oropharyngeal pathogens.","authors":"Tina Peiter, Fergus de Grey-Warter, Tessa Stahl, Thomas Hallet, Derek Matthews, Maren Eggers","doi":"10.3205/dgkh000530","DOIUrl":"https://doi.org/10.3205/dgkh000530","url":null,"abstract":"<p><strong>Aim: </strong>Too often, antibiotics are prescribed in the treatment of pharyngitis, which can contribute to antimicrobial resistance. We aimed to assess the in vitro antiviral and antimicrobial activity of sugar-free cetylpyridinium chloride (CPC)/benzocaine lozenges, which can potentially offer a more suitable treatment for pharyngitis.</p><p><strong>Methods: </strong>The antiviral activity of sugar-free CPC/benzocaine (1.4 mg/10 mg) lozenges (Dolo-Dobendan 1.4 mg/10 mg lozenges) was assessed using the DIN EN 14476:2019-10 suspension test against bovine coronavirus (S379 Reims) or influenza virus A (H1N1/Brisbane/59/2007) under clean and dirty conditions. Viral titers were measured after 1, 5, 10, and 30 min exposure; a reduction of ≥4 lg was considered virucidal. For bovine coronavirus, large volume plating was used due to cytotoxicity. Antimicrobial activity was measured against 11 microorganisms associated with pharyngitis, with contact times of 1, 5, and 10 min (+30 min for positive control).</p><p><strong>Results: </strong>For influenza, sugar-free lozenges showed ≥4 lg efficacy from 5 and 10 min exposure under clean and dirty conditions, respectively. For bovine coronavirus, sugar-free lozenges exhibited ≥4 lg efficacy at 10 min under both conditions. Bactericidal activity was observed against nine of the challenge microorganisms within 5 min, with plate counts of <10 colony-forming units (CFU)/mL for <i>Pseudomonas aeruginosa</i>, <i>Staphylococcus aureus</i>, <i>Arcanobacterium haemolyticum</i>, <i>Moraxella catarrhalis</i>, <i>Porphyromonas gingivalis</i>, <i>Prevotelia intermedia</i>, <i>Streptococcus dysgalactiae</i>, and <i>Streptococcus pyogenes</i>, and <100 CFU/mL for <i>Streptococcus pneumoniae. Candida albicans and Escherichia coli</i> showed counts of <10 CFU/mL at 30 min.</p><p><strong>Conclusions: </strong>Sugar-free CPC/benzocaine lozenges can be recommended for uncomplicated pharyngitis and may be more appropriate than antibiotics, helping to mitigate antimicrobial resistance.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"20 ","pages":"Doc01"},"PeriodicalIF":1.7,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12059798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actinomycosis masquerading as a nasal polyp - a rare entity and diagnostic challenge. 伪装成鼻息肉的放线菌病-一种罕见的实体和诊断挑战。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI: 10.3205/dgkh000520
Revathy Sakthimohan, Ajitha Rajalingam, Thanka Johnson, K Vivek Rajan

Actinomycosis is an endogenous bacterial infection caused by Actinomyces israelii. This bacterium reside on the mucosa of oral cavity, tonsils, and genitourinary tract. Any insult such as trauma, surgery, or foreign body disrupts the mucosal barrier and gives entry to the underlying tissue to cause disease. We describe a rare presentation of Actinomycosis presenting as a nasal polypoidal mass in a young female, an uncommon presentation, thereby causing diagnostic challenge as it may mimic other lesions with similar clinical presentations like fungal polyps, allergic polyps or chronic sinusitis. A 22 year old female presented with history of recurrent upper respiratory tract infection to the ENT Outpatient Department, clinical evaluation showed deviated nasal septum and radiology showed a nasal polyp and patient underwent submucosal resection with middle meatal antrostomy and micro-debrider assisted polypectomy. Histopathology showed respiratory epithelium with underlying stroma showing dense basophilic filamentous organisms surrounded by peripheral eosinophilic clubs that were Gram-positive and Gomori Methanamine Silver stain positive. The disease was diagnosed as Actinomycosis. The disease is a mimicker of various diseases such as nocardiosis, botryomycosis or tuberculosis having a wide range of symptoms and affecting multiple organs. Prevalence of actinomycosis in nasal region is rare thereby increasing the risk of misdiagnosis. Thus, Actinomycosis should be kept as a differential diagnosis in any chronic infectious diseases of the nasal cavity and monitored closely to ensure precise diagnosis and timely management.

放线菌病是由以色列放线菌引起的内源性细菌感染。这种细菌存在于口腔、扁桃体和泌尿生殖道的粘膜上。任何损伤,如创伤、手术或异物都会破坏粘膜屏障,使其进入下层组织而引起疾病。我们描述了一个罕见的放线菌病的表现,表现为一个年轻女性的鼻息肉样肿块,一个不常见的表现,从而引起诊断挑战,因为它可能模仿其他病变类似的临床表现,如真菌息肉,过敏性息肉或慢性鼻窦炎。女,22岁,以反复上呼吸道感染病史就诊于耳鼻喉科,临床检查显示鼻中隔偏曲,影像学检查显示鼻息肉,行粘膜下切除术联合中金属窦口造口及微清创术辅助息肉切除术。组织病理学检查显示,呼吸上皮下层间质可见致密的嗜碱性丝状生物,周围有嗜酸性俱乐部,革兰氏阳性,Gomori甲烷胺银染色阳性。诊断为放线菌病。该病是诺卡菌病、芽孢杆菌病或肺结核等多种疾病的模拟物,症状广泛,影响多个器官。放线菌病的流行在鼻腔区域是罕见的,从而增加了误诊的风险。因此,放线菌病在任何慢性鼻腔感染性疾病中都应作为鉴别诊断,并密切监测,以确保准确诊断和及时处理。
{"title":"Actinomycosis masquerading as a nasal polyp - a rare entity and diagnostic challenge.","authors":"Revathy Sakthimohan, Ajitha Rajalingam, Thanka Johnson, K Vivek Rajan","doi":"10.3205/dgkh000520","DOIUrl":"10.3205/dgkh000520","url":null,"abstract":"<p><p>Actinomycosis is an endogenous bacterial infection caused by <i>Actinomyces israelii</i>. This bacterium reside on the mucosa of oral cavity, tonsils, and genitourinary tract. Any insult such as trauma, surgery, or foreign body disrupts the mucosal barrier and gives entry to the underlying tissue to cause disease. We describe a rare presentation of Actinomycosis presenting as a nasal polypoidal mass in a young female, an uncommon presentation, thereby causing diagnostic challenge as it may mimic other lesions with similar clinical presentations like fungal polyps, allergic polyps or chronic sinusitis. A 22 year old female presented with history of recurrent upper respiratory tract infection to the ENT Outpatient Department, clinical evaluation showed deviated nasal septum and radiology showed a nasal polyp and patient underwent submucosal resection with middle meatal antrostomy and micro-debrider assisted polypectomy. Histopathology showed respiratory epithelium with underlying stroma showing dense basophilic filamentous organisms surrounded by peripheral eosinophilic clubs that were Gram-positive and Gomori Methanamine Silver stain positive. The disease was diagnosed as Actinomycosis. The disease is a mimicker of various diseases such as nocardiosis, botryomycosis or tuberculosis having a wide range of symptoms and affecting multiple organs. Prevalence of actinomycosis in nasal region is rare thereby increasing the risk of misdiagnosis. Thus, Actinomycosis should be kept as a differential diagnosis in any chronic infectious diseases of the nasal cavity and monitored closely to ensure precise diagnosis and timely management.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"19 ","pages":"Doc65"},"PeriodicalIF":1.7,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: an infant with late-onset meningitis caused by Escherichia coli. 病例报告:一例由大肠杆菌引起的迟发性脑膜炎婴儿。
IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-12-16 eCollection Date: 2024-01-01 DOI: 10.3205/dgkh000522
Aria Asghari, Saeed Khoshnood, Zahra Mousavi, Hamid Heidari, Farzaneh Peik Falak, Farhad Dadgar, Hossein Ali Rahdar, Hossein Kazemian

Background: Meningitis is highly prevalent in infant because their immune system is immature and they have less resistance to diseases. Among bacterial agents, Escherichia coli is recognized as one of the most important causes of meningitis in infants.

Case presentation: Herein, we report a case of late-onset meningitis, caused by E. coli (Patient:17-day-old female infant). The patient's body temperature was 39°C, and the initial diagnosis was sepsis. At the doctor's request, the patient underwent the basic tests and was hospitalized in the Neonatal Intensive Care Unit (NICU). In this case, blood culture and CSF culture were negative and positive, respectively. Echogenic particles were observed inside the bladder, indicating possible cystitis. The results of the antibiotic susceptibility tests showed that the meningitis-causing strain of E. coli was susceptible only to amikacin.

Conclusion: Conducting LP and CSF culture seems to be the most important strategy for diagnosing meningitis. It is also recommended to perform LP before taking antibiotics. For identifying the infection, some factors such as fever, CRP test results, CSF parameters (leukocyte count, glucose level, and CSF culture results) should be considered to prevent misdiagnosis.

背景:脑膜炎在婴儿中非常普遍,因为他们的免疫系统不成熟,对疾病的抵抗力较弱。在细菌病原体中,大肠杆菌被认为是导致婴儿脑膜炎的最重要原因之一。病例介绍:在此,我们报告一例由大肠杆菌引起的迟发性脑膜炎(患者:17天大的女婴)。患者体温39℃,初步诊断败血症。在医生的要求下,病人接受了基本检查,并住进新生儿重症监护病房。本例血培养阳性,脑脊液培养阴性。膀胱内可见回声颗粒,提示可能有膀胱炎。抗生素药敏试验结果表明,引起脑膜炎的大肠杆菌菌株仅对阿米卡星敏感。结论:LP和CSF培养是诊断脑膜炎最重要的方法。建议在服用抗生素前进行LP检查。诊断感染时应考虑发热、CRP检测结果、脑脊液参数(白细胞计数、血糖水平、脑脊液培养结果)等因素,防止误诊。
{"title":"Case report: an infant with late-onset meningitis caused by Escherichia coli.","authors":"Aria Asghari, Saeed Khoshnood, Zahra Mousavi, Hamid Heidari, Farzaneh Peik Falak, Farhad Dadgar, Hossein Ali Rahdar, Hossein Kazemian","doi":"10.3205/dgkh000522","DOIUrl":"10.3205/dgkh000522","url":null,"abstract":"<p><strong>Background: </strong>Meningitis is highly prevalent in infant because their immune system is immature and they have less resistance to diseases. Among bacterial agents, <i>Escherichia coli</i> is recognized as one of the most important causes of meningitis in infants.</p><p><strong>Case presentation: </strong>Herein, we report a case of late-onset meningitis, caused by <i>E. coli</i> (Patient:17-day-old female infant). The patient's body temperature was 39°C, and the initial diagnosis was sepsis. At the doctor's request, the patient underwent the basic tests and was hospitalized in the Neonatal Intensive Care Unit (NICU). In this case, blood culture and CSF culture were negative and positive, respectively. Echogenic particles were observed inside the bladder, indicating possible cystitis. The results of the antibiotic susceptibility tests showed that the meningitis-causing strain of <i>E. coli</i> was susceptible only to amikacin.</p><p><strong>Conclusion: </strong>Conducting LP and CSF culture seems to be the most important strategy for diagnosing meningitis. It is also recommended to perform LP before taking antibiotics. For identifying the infection, some factors such as fever, CRP test results, CSF parameters (leukocyte count, glucose level, and CSF culture results) should be considered to prevent misdiagnosis.</p>","PeriodicalId":12738,"journal":{"name":"GMS Hygiene and Infection Control","volume":"19 ","pages":"Doc67"},"PeriodicalIF":1.7,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142983330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
GMS Hygiene and Infection Control
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1